These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28716525)

  • 21. MRC-5 Cancer-associated Fibroblasts Influence Production of Cancer Stem Cell Markers and Inflammation-associated Cell Surface Molecules, in Liver Cancer Cell Lines.
    Ding SM; Lu JF; Edoo MIA; Zhou L; Xie HY; Zheng SS; Li QY
    Int J Med Sci; 2019; 16(8):1157-1170. PubMed ID: 31523179
    [No Abstract]   [Full Text] [Related]  

  • 22. Secretion of interleukin-6 by bone marrow mesenchymal stem cells promotes metastasis in hepatocellular carcinoma.
    Mi F; Gong L
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28659496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.
    Ng KY; Chai S; Tong M; Guan XY; Lin CH; Ching YP; Xie D; Cheng AS; Ma S
    Oncotarget; 2016 Apr; 7(17):24005-17. PubMed ID: 27006468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-6 and PD-L1 blockade combination inhibits hepatocellular carcinoma cancer development in mouse model.
    Liu H; Shen J; Lu K
    Biochem Biophys Res Commun; 2017 Apr; 486(2):239-244. PubMed ID: 28254435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxiredoxin II Is Essential for Maintaining Stemness by Redox Regulation in Liver Cancer Cells.
    Kwon T; Bak Y; Park YH; Jang GB; Nam JS; Yoo JE; Park YN; Bak IS; Kim JM; Yoon DY; Yu DY
    Stem Cells; 2016 May; 34(5):1188-97. PubMed ID: 26866938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma.
    Cheung PF; Cheung TT; Yip CW; Ng LW; Fung SW; Lo CM; Fan ST; Cheung ST
    Oncotarget; 2016 Apr; 7(16):21644-57. PubMed ID: 26942873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY
    Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis.
    Sukowati CH; Anfuso B; Crocé LS; Tiribelli C
    BMC Cancer; 2015 Mar; 15():188. PubMed ID: 25879842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microfilament regulatory protein MENA increases activity of RhoA and promotes metastasis of hepatocellular carcinoma.
    Lin L; Yang XM; Li J; Zhang YL; Qin W; Zhang ZG
    Exp Cell Res; 2014 Sep; 327(1):113-22. PubMed ID: 24859350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spatial multiomics reveals a subpopulation of fibroblasts associated with cancer stemness in human hepatocellular carcinoma.
    Jing SY; Liu D; Feng N; Dong H; Wang HQ; Yan X; Chen XF; Qu MC; Lin P; Yi B; Feng F; Chen L; Wang HY; Li H; He YF
    Genome Med; 2024 Aug; 16(1):98. PubMed ID: 39138551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ASPP2 suppresses stem cell-like characteristics and chemoresistance by inhibiting the Src/FAK/Snail axis in hepatocellular carcinoma.
    Xu L; Tong X; Zhang S; Yin F; Li X; Wei H; Li C; Guo Y; Zhao J
    Tumour Biol; 2016 Oct; 37(10):13669-13677. PubMed ID: 27473084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer-Associated Fibroblast-Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression.
    Song M; He J; Pan QZ; Yang J; Zhao J; Zhang YJ; Huang Y; Tang Y; Wang Q; He J; Gu J; Li Y; Chen S; Zeng J; Zhou ZQ; Yang C; Han Y; Chen H; Xiang T; Weng DS; Xia JC
    Hepatology; 2021 May; 73(5):1717-1735. PubMed ID: 33682185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course.
    Muramatsu S; Tanaka S; Mogushi K; Adikrisna R; Aihara A; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Nakayama K; Tanaka H; Yamaoka S; Arii S
    Hepatology; 2013 Jul; 58(1):218-28. PubMed ID: 23447025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oct4 is a reliable marker of liver tumor propagating cells in hepatocellular carcinoma.
    Wu G; Wilson G; Zhou G; Hebbard L; George J; Qiao L
    Discov Med; 2015 Oct; 20(110):219-29. PubMed ID: 26562475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRC-5 fibroblast-conditioned medium influences multiple pathways regulating invasion, migration, proliferation, and apoptosis in hepatocellular carcinoma.
    Ding S; Chen G; Zhang W; Xing C; Xu X; Xie H; Lu A; Chen K; Guo H; Ren Z; Zheng S; Zhou L
    J Transl Med; 2015 Jul; 13():237. PubMed ID: 26198300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgen/androgen receptor axis maintains and promotes cancer cell stemness through direct activation of Nanog transcription in hepatocellular carcinoma.
    Jiang L; Shan J; Shen J; Wang Y; Yan P; Liu L; Zhao W; Xu Y; Zhu W; Su L; Chen J; Cheng F; Yao H; Xu H; Qian C; Liang Z
    Oncotarget; 2016 Jun; 7(24):36814-36828. PubMed ID: 27167111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Notch pathway promotes the cancer stem cell characteristics of CD90+ cells in hepatocellular carcinoma.
    Luo J; Wang P; Wang R; Wang J; Liu M; Xiong S; Li Y; Cheng B
    Oncotarget; 2016 Feb; 7(8):9525-37. PubMed ID: 26848615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells.
    Oikawa T; Wauthier E; Dinh TA; Selitsky SR; Reyna-Neyra A; Carpino G; Levine R; Cardinale V; Klimstra D; Gaudio E; Alvaro D; Carrasco N; Sethupathy P; Reid LM
    Nat Commun; 2015 Oct; 6():8070. PubMed ID: 26437858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.